PIEZO1 and non-small cell lung carcinoma: Huang et al. showed that the Piezo1 deletion variants in non-small cell lung cancer (NSCLC) lead to down-regulation of its expression, and, furthermore, the low level of Piezo1 is associated with poor prognosis in NSCLC patients [39].